Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  H. Lundbeck A/S    LUN   DK0010287234

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo H. Lundbeck A/S
Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders.

It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.

Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's.

The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.

Number of employees : 5 257 persons.
Sales per Businesses
20142015Delta
DKK (in Million)%DKK (in Million)%
Cipralex4,64734.5%---
Other Pharmaceuticals1,98514.7%---
Xenazine1,69512.6%---
Azilect1,49711.1%---
Ebixa1,0587.9%---
Onfi923.006.9%---
Sabril716.005.3%---
Other Revenue547.004.1%---
Treanda212.001.6%---
Brintellix188.001.4%---
Pharmaceuticals--14,594100.9%-
Sales per Regions
20142015Delta
DKK (in Million)%DKK (in Million)%
Rest of Europe4,99137.1%3,86926.7% -22.48%
International4,14430.8%3,82726.5% -7.65%
United States3,75827.9%6,35343.9% +69.05%
Other Revenue547.004.1%518.003.6% -5.3%
Denmark28.000.2%27.000.2% -3.57%
Managers
NameAgeSinceTitle
Kåre Schultz562015President & Chief Executive Officer
Lars Søren Rasmussen582013Chairman
Anders Götzsche502007CFO & Executive VP-Information Technology
Lars Bang551988EVP-Supply Operations & Engineering
Anders Gersel Pedersen MD, PhD662000Executive Vice President-Research & Development
Jørn Møller Mayntzhusen, MBA512002Director & Senior Manager-Supply Optimisation
Mona Elisabeth Elster551994Director
Terrie Curran482014Independent Director
Henrik Sindal Jensen, PhD482004Director
Lene Skole-Sørensen582015Deputy Chairman
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 197,619,721 59,643,877 30.2% 623,926 0.3% 30.2%
Shareholders
NameEquities%
Lundbeck Foundation 137,351,918 69.5%
Wellington Management Co. LLP 4,610,434 2.33%
OppenheimerFunds, Inc. 4,540,846 2.30%
TIAA-CREF Investment Management LLC 3,009,078 1.52%
Norges Bank Investment Management 1,963,697 0.99%
Teachers Advisors, Inc. 1,939,444 0.98%
Templeton Global Advisors Ltd. 1,704,801 0.86%
Oddo Meriten Asset Management SA 1,466,548 0.74%
Nordea Investment Management AB (Denmark) 1,429,436 0.72%
The Vanguard Group, Inc. 1,169,238 0.59%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
H. LUNDBECK A/S1.98%8 333
JOHNSON & JOHNSON-0.92%310 549
ROCHE HOLDING LTD.1.29%200 499
PFIZER INC.-2.19%192 792
NOVARTIS AG-4.32%185 152
MERCK & CO., INC.6.22%172 404
SANOFI-1.66%104 532
GLAXOSMITHKLINE PLC-0.67%93 916
BAYER AG1.33%90 687
ELI LILLY AND CO4.43%84 794
BRISTOL-MYERS SQUIBB C..-15.76%82 275
ALLERGAN PLC2.06%80 395
NOVO NORDISK A/S-1.65%72 057
ABBOTT LABORATORIES5.34%69 842
ASTRAZENECA PLC3.22%67 430
SHIRE PLC-6.21%49 020
TAKEDA PHARMACEUTICAL ..-2.50%32 494
ASTELLAS PHARMA INC-5.04%29 002
MYLAN NV-2.83%19 836
EISAI CO., LTD-3.44%16 749
CHUGAI PHARMACEUTICAL ..1.64%16 644
Sector Pharmaceuticals - NEC
H. Lundbeck A/S : Connections
Fonden Lundbeck International Neuroscience Foundation
Rosborg Møbler A/S
Danish Society of Medical Oncology
Confederation of Danish Industry
Fertin Pharma A/S
International Association for the Study of Lung Cancer
Lundbeckfond Invest A/S
Danish Society of Internal Medicine
American Chamber of Commerce Executives, Inc.
Tryg Forsikring A/S
Coloplast Ejendomme A/S
Lfi Equity A/S
Lundbeck Pharma A/S
LEGO A/S
Lundbeck Cognitive Therapeutics A/S
The British Chambers of Commerce
European Society for Medical Oncology
Coloplast Danmark A/S
American Society of Clinical Oncology
Company contact information
9 Ottiliavej
DK 2500 Valby, Copenhagen
Denmark

Phone : +45 36 30 13 11
Fax : +45 36 30 19 40
Internet : http://www.lundbeck.com
Markets and indexes
- NASDAQ OMX nordic Kopenhagen
- Main Market Large
- OMXC 20 /
Stock Exchange Codes
- ISIN Code :  DK0010287234
- Bloomberg Code :  LUN:DC
- Reuters Code :  LUN.CO
- Datastream Code :  DK:LUND
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem